NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

PCF-H180AL/I Colonoscope

The PCF-H180AL/I colonoscope provides detailed images with a high-definition HDTV image sensor, while Narrow Band Imaging (NBI) illuminates mucosal and vascular patterns. The Close Focus function allows up-close viewing with no loss of resolution. The auxiliary water function can be combined with dedicated flushing pump, enabling removal of mucus and clots in the colon at the touch of a switch on the scope or on the footswitch unit. Innoflex Variable Stiffness capability allows adjustment of insertion tube flexibility to match the conditions and contours of the colon. The 3.2mm diameter channel accommodates a wide range of treatment devices. The insertion tube measures 11.8 mm across. Scope ID function stores individual scope information in the built-in memory chip and displays it on the monitor.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X